John Germak, MD, Novo Nordisk Inc, Princeton, NJ
Sponsored by the Corporate Liaison Board of the Endocrine Society, this yearly forum highlights the collaboration between industry, academia, and healthcare agencies from both government and non-government organizations in approaches to treatment of endocrine disorders. Enhance your ENDO 2016 experience with this special session. Speakers representing clinical science and industry will discuss current science and future research for preventing and treating obesity.
KLG: Vice President, Novo Nordisk.
JAY: Principal Investigator, Zafgen, Inc..